3
IRUS TotalDownloads
Altmetric
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
File | Description | Size | Format | |
---|---|---|---|---|
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes.pdf | Published version | 21.75 MB | Adobe PDF | View/Open |
Title: | Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes |
Authors: | Nguyen, LV Phung, KL Ming, DKY Huynh, TLD Nguyet, MN Dong, THT Kien, DTH Chau, NVV Chanpheaktra, N Lum, LCS Pleites, E Simmons, CP Rosenberger, KD Jaenisch, T Bell, D Acestor, N Halleux, C Olliaro, PL Wills, BA Geskus, RB Yacoub, S |
Item Type: | Journal Article |
Abstract: | Background: Early identification of severe dengue patients is important regarding patient management and resource allocation. We investigated the association of 10 biomarkers (VCAM-1, SDC-1, Ang-2, IL-8, IP-10, IL-1RA, sCD163, sTREM-1, ferritin, CRP) with the development of severe/moderate dengue (S/MD). Methods: We performed a nested case-control study from a multi-country study. A total of 281 S/MD and 556 uncomplicated dengue cases were included. Results: On days 1–3 from symptom onset, higher levels of any biomarker increased the risk of developing S/MD. When assessing together, SDC-1 and IL-1RA were stable, while IP-10 changed the association from positive to negative; others showed weaker associations. The best combinations associated with S/MD comprised IL-1RA, Ang-2, IL-8, ferritin, IP-10, and SDC-1 for children, and SDC-1, IL-8, ferritin, sTREM-1, IL-1RA, IP-10, and sCD163 for adults. Conclusions: Our findings assist the development of biomarker panels for clinical use and could improve triage and risk prediction in dengue patients. Funding: This study was supported by the EU's Seventh Framework Programme (FP7-281803 IDAMS), the WHO, and the Bill and Melinda Gates Foundation. |
Issue Date: | 22-Jun-2021 |
Date of Acceptance: | 11-Jun-2021 |
URI: | http://hdl.handle.net/10044/1/95051 |
DOI: | 10.7554/eLife.67460 |
ISSN: | 2050-084X |
Publisher: | eLife Sciences Publications Ltd |
Journal / Book Title: | eLife |
Volume: | 10 |
Copyright Statement: | © 2021, Vuong et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
Keywords: | Science & Technology Life Sciences & Biomedicine Biology Life Sciences & Biomedicine - Other Topics This study was supported by the EU's Seventh Framework Programme (FP7-281803 IDAMS) the WHO and the Bill and Melinda Gates Foundation HEMORRHAGIC-FEVER BIOMARKER PANEL SERUM-LEVELS DISEASE PROGRESSION PREDICTION SELECTION biomarkers dengue infectious disease medicine microbiology prognostic virus Adolescent Adult Biomarkers Case-Control Studies Child Child, Preschool Cytokines Dengue Female Humans Inflammation Male Young Adult Humans Dengue Inflammation Cytokines Case-Control Studies Adolescent Adult Child Child, Preschool Female Male Young Adult Biomarkers Science & Technology Life Sciences & Biomedicine Biology Life Sciences & Biomedicine - Other Topics This study was supported by the EU's Seventh Framework Programme (FP7-281803 IDAMS) the WHO and the Bill and Melinda Gates Foundation HEMORRHAGIC-FEVER BIOMARKER PANEL SERUM-LEVELS DISEASE PROGRESSION PREDICTION SELECTION 0601 Biochemistry and Cell Biology |
Publication Status: | Published |
Article Number: | ARTN e67460 |
Online Publication Date: | 2021-08-03 |
Appears in Collections: | Department of Infectious Diseases |
This item is licensed under a Creative Commons License